Prot# GZ/SAR402671 - ACT1482: Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GZ/SAR402671 in Patients with Early-Stage Parkinson’s Disease Carrying a GBA Mutation o